Concepedia

D. Mark Layton

DM

Statistics

Publications

15

Citations

1K

H-Index

14

Active since

1988

Affiliations

Imperial College Healthcare NHS Trust(Current)

Hammersmith Hospital

Imperial College London

University College London

King's College London

D. Mark Layton is an author at Imperial College Healthcare NHS Trust specializing in medicine, hematology, and sickle cell anemia.

Publications per year

1988–2022

15

Publications

15

Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency

Rachael F. Grace, Christian Rosé, D. Mark Layton et al. · New England Journal of Medicine · 2019 · 159 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

THE LABORATORY DIAGNOSIS OF HAEMOGLOBINOPATHIES

Barbara J. Bain, R. Amos, D. Bareford et al. · British Journal of Haematology · 1998 · 148 citations · Full text

Life Sciences, Genetics, Hematology +16

Rapid Identification of Hemoglobin Variants by Electrospray Ionization Mass Spectrometry

Barbara Wild, B.N. Green, Elaine Cooper et al. · Blood Cells Molecules and Diseases · 2001 · 122 citations

Pharmacy, Biochemistry, Hematology +14

A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease

Jo Howard, Claire Hemmaway, Paul Telfer et al. · Blood · 2019 · 112 citations · Full text

Medicine, Hematology, Diagnostic Imaging +7

Mitapivat versus Placebo for Pyruvate Kinase Deficiency

Hanny Al‐Samkari, F. Galactéros, Andreas Glenthøj et al. · New England Journal of Medicine · 2022 · 94 citations · Full text

Medicine, Hematology, Pharmacology +13

1–5 of 15